With a strong emphasis on patient relevance, projects should align with key priorities such as identifying individuals at risk, preventing disease onset through immune-based strategies, and improving therapies that help patients live well.
The funding will help build research capacity by supporting early- and mid-career scientists, while leveraging Oxford's strengths in innovation and commercialisation to ensure promising discoveries can quickly progress from initial concepts to clinical development.